findmyKOL

Leena Jha, MD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNone on fileNPI
RegionAlexandria, VA · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2011Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Leena Jha is an Endocrinology/Metabolic physician. OpenAlex indexes 5 publications with 241 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

241citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6355 Walker Ln Ste 405
Alexandria, VA 223103250

Telephone

703-719-6715

Provider last certified this registry record 5 Oct 2022.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    71.6%
    Insulin Analog22.1%
    Lantus Solostar25%Humalog Kwikpen U-10017%Novolog Flexpen17%Basaglar Kwikpen U-10011%Tresiba Flextouch U-10011%Levemir Flexpen5%Fiasp Flextouch3%Admelog Solostar3%Insulin Aspart Flexpen3%Toujeo Max Solostar3%Tresiba Flextouch U-2003%
    Part D<11 patients
    Biguanide (metformin)14.9%
    Metformin Hcl51%Metformin Hcl Er49%
    Part D58 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    25.2%
    l-Thyroxine23.3%
    Levothyroxine Sodium75%Synthroid26%
    Part D118 patients
    Thyroid Hormone Synthesis Inhibitor1.4%
    Methimazole100%
    Part D13 patients

    + 1 more class in this area

  • Cardiovascular

    2%
    Statin1.3%
    Atorvastatin Calcium60%Simvastatin40%
    Part D<11 patients
    ACE inhibitor0.7%
    Lisinopril100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”